<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article article-type="research-article" dtd-version="3.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0147056</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-41529</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Melanomas</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Alkaloids</subject><subj-group><subject>Caffeine</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Cohort studies</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Case-control studies</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject><subj-group><subject>Beverages</subject><subj-group><subject>Coffee</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject><subj-group><subject>Beverages</subject><subj-group><subject>Coffee</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Carcinogenesis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell processes</subject><subj-group><subject>Cell death</subject><subj-group><subject>Apoptosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study</article-title>
<alt-title alt-title-type="running-head">Coffee Intake and MM Risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Jibin</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Shen</surname>
<given-names>Biao</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Shi</surname>
<given-names>Minxin</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Cai</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="corresp" rid="cor001">*</xref>
<xref ref-type="aff" rid="aff001"/>
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Nantong Tumor Hospital, Nantong Pingchao town, Tong yang Rd. 30, 226361, Jiangsu province, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Villa</surname>
<given-names>Erica</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Modena &amp; Reggio Emilia, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: JL JC. Performed the experiments: JL BS MS. Analyzed the data: JL JC. Contributed reagents/materials/analysis tools: JL BS MS. Wrote the paper: JL JC.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">caijingnantong@sina.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>1</issue>
<elocation-id>e0147056</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>12</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Liu et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0147056"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Several epidemiological studies have determined the associations between coffee intake level and skin cancer risk; however, the results were not yet conclusive. Herein, we conducted a systematic review and meta-analysis of the cohort and case-control studies for the association between coffee intake level and malignant melanoma (MM) risk.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>Studies were identified through searching the PubMed and MEDLINE databases (to November, 2015). Study-specific risk estimates were pooled under the random-effects model.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Two case-control studies (846 MM patients and 843 controls) and five cohort studies (including 844,246 participants and 5,737 MM cases) were identified. For caffeinated coffee, the pooled relative risk (RR) of MM was 0.81 [95% confidential interval (95% CI) = 0.68–0.97; P-value for Q-test = 0.003; I<sup>2</sup> = 63.5%] for those with highest versus lowest quantity of intake. In the dose-response analysis, the RR of MM was 0.955 (95% CI = 0.912–0.999) for per 1 cup/day increment of caffeinated coffee consumption and linearity dose-response association was found (P-value for nonlinearity = 0.326). Strikingly, no significant association was found between the decaffeinated coffee intake level and MM risk (pooled RR = 0.92, 95% CI = 0.81–1.05; P-value for Q-test = 0.967; I<sup>2</sup> = 0%; highest versus lowest quantity of intake).</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>This meta-analysis suggested that caffeinated coffee might have chemo-preventive effects against MM but not decaffeinated coffee. However, larger prospective studies and the intervention studies are warranted to confirm these findings.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>This work was supported by the China Post-doctoral Science Foundation (NO: 2013M541563) and the peak of six personnel Foundation in Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="2"/>
<page-count count="14"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Malignant melanoma (MM) is a lethal type of skin cancer, and its incidence has been increasing worldwide for the past several years [<xref ref-type="bibr" rid="pone.0147056.ref001">1</xref>]. Many factors have been identified that may influence the susceptibility of people to MM including ultraviolet (UV)-light exposure, skin phototype, eye and hair color, tanning capacity, presence of freckles and/or precancerous lesions, larger number of common acquired nevi, presence of atypical nevi, and genetic factors [<xref ref-type="bibr" rid="pone.0147056.ref002">2</xref>]. Solar ultraviolet was recognized as one of the most notable environmental factors for MM risk, although many lifestyle and environmental factors influence MM risk through interaction with UV exposure. Several dietary or nutritional factors, including the amount of ingestion of fish, vegetables and fruits, were suggested to have preventative effects against melanoma and a few studies have reported protective roles of beta-carotene and vitamins A, C, D and E on melanoma. However, these identified susceptibility factors only account for a small proportion of melanoma risk [<xref ref-type="bibr" rid="pone.0147056.ref003">3</xref>]. Caffeine, an ingredient found at high concentrations in coffee, has been reported to inhibit UV-induced skin carcinogenesis. Oral administration of caffeine could enhance UV-induced cell apoptosis [<xref ref-type="bibr" rid="pone.0147056.ref004">4</xref>], promote the elimination of DNA damaged cells [<xref ref-type="bibr" rid="pone.0147056.ref004">4</xref>], reduce the inflammation of epidermal cells [<xref ref-type="bibr" rid="pone.0147056.ref005">5</xref>] and inhibit the aberrant DNA methylation of the cells [<xref ref-type="bibr" rid="pone.0147056.ref006">6</xref>]. Moreover, caffeine also inhibits the metastasis of melanoma tumor cells [<xref ref-type="bibr" rid="pone.0147056.ref007">7</xref>] and enhances the radiosensitivity of tumor cells [<xref ref-type="bibr" rid="pone.0147056.ref008">8</xref>]. Therefore, higher coffee intake may have preventative effects against cutaneous melanoma. To date, several epidemiological studies have determined associations between caffeinated coffee intake level and the risk for MM and found that caffeinated coffee may have protective effects against melanoma [<xref ref-type="bibr" rid="pone.0147056.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0147056.ref011">11</xref>]. However, the results for other studies found no such associations [<xref ref-type="bibr" rid="pone.0147056.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0147056.ref014">14</xref>]. In contrast, several epidemiological studies have also evaluated the associations between the decaffeinated coffee and melanoma risk, but none of them found a statistically significant association [<xref ref-type="bibr" rid="pone.0147056.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0147056.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0147056.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0147056.ref015">15</xref>–<xref ref-type="bibr" rid="pone.0147056.ref018">18</xref>]. As the results of the epidemiological studies are inconsistent, we herein systematically reviewed the epidemiological studies that have assessed the associations between the caffeinated or decaffeinated coffee intake level and the risks for MM, and further assessed their associations utilizing meta-analysis methods.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods and Materials</title>
<sec id="sec007">
<title>Eligibility study identification</title>
<p>To identify the eligibility studies that have determined the association between the coffee intake level and the risk for MM, two authors (Liu and Shen) independently searched the PubMED and MEDLINE databases with the terms “melanoma” or”skin cancer” in combination with “coffee” or “caffeine”. The electronic search was performed in November, 2015 and the eligibility studies should be online published online in peer-reviewed journals. The titles, abstracts and the full manuscripts were independently reviewed and assessed by the two authors, and the third author (Cai) joined the assessment of the manuscript if there was any discrepancy. In addition, we further checked the references of the retrieved studies and the published reviews or comments to identify any missing study in the literature search. In brief, the working flow chart of the eligible literature identified was presented as <xref ref-type="fig" rid="pone.0147056.g001">Fig 1</xref>.</p>
<fig id="pone.0147056.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0147056.g001</object-id>
<label>Fig 1</label>
<caption>
<title>The working flow chart for eligible study identification in meta-analysis studies.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec008">
<title>Inclusion and exclusion criteria</title>
<p>Epidemiological studies that were to be included in the current meta-analysis studies should meet the following criteria: 1) was a population- or hospital-based, case-control study or a prospective or retrospective cohort study; 2) provided the coffee intake level category and the corresponding relative risk (RR) or the odds ratio (OR) estimates and their confidential intervals (95% CIs) for MM; 3) not overlapped participants with other included studies. If overlapping populations were identified between studies, the most complete one was included in the meta-analysis; 4) be reported in the English language. Here, we excluded conference abstracts, reviews, ecological studies, cellular studies and animal studies. Studies that concerned the non-melanoma skin cancer were also excluded.</p>
</sec>
<sec id="sec009">
<title>Quality assessment of the included studies</title>
<p>We assessed the quality of the evidence, for each study, on the association between caffeinated or decaffeinated coffee intake level and melanoma risk using the Newcastle-Ottawa quality scale [<xref ref-type="bibr" rid="pone.0147056.ref019">19</xref>]. For case-control or cohort studies, a total of nine points were designated based on the characteristics of the studies including: (1) the selection of comparison groups, total score: 4; (2) the comparability of the groups, total score: 2; (3) the quality of the measurement of exposure and outcome, total score: 3. The total score of the adapted studies ranged between 5 to 7, and we deemed those with a score of 6 or lower as poorer quality studies (<xref ref-type="supplementary-material" rid="pone.0147056.s005">S1 Table</xref>).</p>
</sec>
<sec id="sec010">
<title>Data extraction</title>
<p>The following data was extracted from each study: the last name of the first author, the publication year, the study design (hospital or population based case-control studies or the cohort studies), the country where the study was performed, the sample size (the number of participants for cohort studies and the number of patients and controls for case-control studies), the study period for the cohort studies (the year for the participants recruitment and the last following-up year), the types of coffee (caffeinated or decaffeinated), the method for the exposure assessment, the intake category for the coffee intake level and the corresponding relative risk (RR) or odds ratio (OR) estimates with their 95% confidential intervals (95% CIs), and the adjustments in the statistical analyses. If there were subgroup studies, each subgroup was recognized as individual studies. The meta-analysis studies were performed following the MOOSE (<xref ref-type="supplementary-material" rid="pone.0147056.s003">S1 File</xref>) and PRISMA guidelines (<xref ref-type="supplementary-material" rid="pone.0147056.s004">S2 File</xref>).</p>
</sec>
<sec id="sec011">
<title>Statistical analysis</title>
<p>The inverse variance weighting method was applied to calculate the summary estimates and the 95% CIs. The risk estimates for the highest, in comparison with the lowest, category for each study were extracted or calculated, and the squared inverse variance for the logarithm estimate was considered as the appropriate weight for each study. The ORs from case-control studies were assumed as the estimates of the RRs for prospective studies. The DerSimonian and Laird random-effects model that considers both within- and between-study heterogeneity were used in the pooling analyses [<xref ref-type="bibr" rid="pone.0147056.ref020">20</xref>]. The Cochran's Q-test in together with the I<sup>2</sup> statistic were used to assess the heterogeneity between the studies. Significant heterogeneity was considered when P &lt; 0.05 for Q-test or the I<sup>2</sup> was larger than 25%. To identify any individual study that may significantly affect the pooled estimates, the sensitivity analyses were performed through calculating the pooled risk estimates after excluding each single study from the meta-analysis repeatedly. The publication bias for the studies was assessed with the Begg’s funnel plots and further determined with the Egger’s linear regression test [<xref ref-type="bibr" rid="pone.0147056.ref021">21</xref>,<xref ref-type="bibr" rid="pone.0147056.ref022">22</xref>]. To investigate the influence of the basic characteristics of the individual studies on the heterogeneity between the results of multiple studies, the meta-regression analyses were performed. We also applied the generalized least square estimated trend (GLST) analysis methods proposed by Orsini et al. [<xref ref-type="bibr" rid="pone.0147056.ref023">23</xref>] to evaluate the dose-response relationship between coffee intake and MM risk in the prospective cohort studies. The restricted cubic spline methods with three knots at 10%, 50% and 90% for the distribution of daily caffeinated coffee intake were used to evaluate the linear relationship between coffee intake and MM risk. All statistical analyses were performed with R (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org" xlink:type="simple">www.r-project.org</ext-link>), Stata (version 11.0, StataCorp) and Review Manager (version 5.2.10) software. Two-sided P &lt; 0.05 was considered to be statistically significant.</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Literature search and study characteristics</title>
<p>In the literature search, we have identified seven articles, reported from two case-control studies [<xref ref-type="bibr" rid="pone.0147056.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0147056.ref016">16</xref>] and five cohort studies that have determined the association between the coffee intake level and the MM risk [<xref ref-type="bibr" rid="pone.0147056.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0147056.ref011">11</xref>–<xref ref-type="bibr" rid="pone.0147056.ref014">14</xref>]. The basic characteristics of the included studies are presented in <xref ref-type="table" rid="pone.0147056.t001">Table 1</xref>. The two case-control studies, both of which were conducted in Italy, have recruited a total of 846 MM patients and 843 controls. Five prospective cohort reports with eight subgroups involved a total of 844,246 participants and 5,737 cases. Of them, three were performed in the United States and one in Norway (<xref ref-type="table" rid="pone.0147056.t001">Table 1</xref>). According to the Newcastle-Ottawa quality scale guidelines, three studies were designated as being conducted with poorer quality and three studies were conducted with better quality (<xref ref-type="supplementary-material" rid="pone.0147056.s005">S1 Table</xref>).</p>
<table-wrap id="pone.0147056.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0147056.t001</object-id>
<label>Table 1</label> <caption><title>The basic characteristics for the eligibility studies included in the meta-analysis studies.</title></caption>
<alternatives>
<graphic id="pone.0147056.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<tbody>
<tr>
<td align="left"><bold>First author, Year (Ref)</bold></td>
<td align="center"><bold>Study design</bold></td>
<td align="center"><bold>Region</bold></td>
<td align="center"><bold>Participants</bold></td>
<td align="center"><bold>Subgroup, exposure assessment</bold></td>
<td align="left"><bold>Intake category</bold></td>
<td align="center"><bold>OR/RR (95% CI)</bold></td>
<td align="center"><bold>Adjustments</bold></td>
</tr>
<tr>
<td align="center"><bold>Naldi L, 2004 (16)</bold></td>
<td align="center">Hospital based case-control</td>
<td align="center">Italy</td>
<td align="center">542 cutaneous malignant melanoma cases and 538 controls</td>
<td align="center">Caffeinated coffee, structured questionnaire</td>
<td align="left">&lt;1 cup per day/1 cup per day/2 cups per day/3 cups per day/≥4 cups per day</td>
<td align="center">Referent/1.26 (0.85–1.87)/1.14 (0.77–1.67)/1.29 (0.81–2.04)/1.15 (0.68–1.92)</td>
<td align="left">Age, sex, education, BMI, history of sunburns, propensity to sunburns, number of naevi, number of freckles, skin, hair and eye colour, and smoking.</td>
</tr>
<tr>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center">Decaffeinated coffee, structured questionnaire</td>
<td align="left">Non-drinkers/Drinkers</td>
<td align="center">Referent/0.84 (0.60–1.18)</td>
<td align="left">The same as above.</td>
</tr>
<tr>
<td align="center"><bold>Fortes C, 2013 (10)</bold></td>
<td align="center">Hospital based case-control</td>
<td align="center">Italy</td>
<td align="center">304 melanoma cases and 305 controls</td>
<td align="center">Caffeinated coffee, structured questionnaire</td>
<td align="left">≤1 cup per day/&gt; 1 cup/day</td>
<td align="center">Referent/0.53 (0.38–0.74)</td>
<td align="left">Age and sex.</td>
</tr>
<tr>
<td align="center"><bold>Veierod M, 1997 (11)</bold></td>
<td align="center">Prospective cohort</td>
<td align="center">Norway</td>
<td align="center">25,049 women (47 cases) and 25,708 men (61 cases) (1974–1976 to 1977–1983)</td>
<td align="center">Caffeinated coffee in women, FFQ</td>
<td align="left">≤ 2 cups per day/3-4 cups per day/5-6 cups per day/≥ 7 cups per day</td>
<td align="center">Referent/0.6 (0.3–1.1)/0.4 (0.2–0.8)/0.4 (0.2–0.8)/0.4 (0.2–0.9)</td>
<td align="left">County of residence, age at inclusion and attained age.</td>
</tr>
<tr>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center">Caffeinated coffee in men, FFQ</td>
<td align="left">≤ 2 cups per day/3-4 cups per day/5-6 cups per day/≥7 cups per day</td>
<td align="center">Referent/2.4 (0.8–7.1)/1.9 (0.6–5.7)/1.5 (0.5–4.6)</td>
<td align="left">County of residence, age at inclusion and attained age.</td>
</tr>
<tr>
<td align="left"><bold>Nilson L, 2010 (14)</bold></td>
<td align="left">Prospective cohort</td>
<td align="left">Sweden</td>
<td align="center">76,338 residues, 108 cases (1992–2007)</td>
<td align="center">Caffeinated coffee, FFQ</td>
<td align="left">&lt; 1 cups per day/1-3 cups per day/≥7 cups per day</td>
<td align="center">Referent/0.91 (0.48–1.70)/0.97 (0.50–1.89)</td>
<td align="left">Age, sex, BMI, smoking, education, and recreational physical activity.</td>
</tr>
<tr>
<td align="left"><bold>First author, Year (Ref)</bold></td>
<td align="left"><bold>Study design</bold></td>
<td align="left"><bold>Region</bold></td>
<td align="left"><bold>Participants</bold></td>
<td align="left"><bold>Subgroup, exposure assessment</bold></td>
<td align="left"><bold>Intake category</bold></td>
<td align="center"><bold>OR/RR (95% CI)</bold></td>
<td align="left"><bold>Adjustments</bold></td>
</tr>
<tr>
<td align="center"><bold>Wu H, 2015 (12)</bold></td>
<td align="center">Prospective cohort (Women's Health Initiative-Observational Study, WHI-OS)</td>
<td align="center">USA</td>
<td align="center">66,484 postmenopausal women, 363 cases (1993–1998 to September 2005)</td>
<td align="center">Caffeinated coffee, NA</td>
<td align="left">&lt; 1 cup per day/1 cup per day/2-3 cups per day/&gt; 4 cups per day</td>
<td align="center">Referent/0.85 (0.60–1.19)/0.96 (0.73–1.26)/1.01 (0.67–1.53)</td>
<td align="left">Age, height, waist-hip ratio, education, income, alcohol, smoking, region of residence, aspirin, history of nonmelanoma skin cancer, kin reaction to sun, sunscreen use, and summer sunlight exposure in the 30s.</td>
</tr>
<tr>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center">Decaffeinated coffee, NA</td>
<td align="left">&lt; 1 cup per day/1 cup per day/ 2–3 cups per day/&gt; 4 cups per day</td>
<td align="center">Referent/0.77 (0.55–1.09)/1.00 (0.73–1.38)/0.73 (0.36–1.49)</td>
<td align="left">The same as above.</td>
</tr>
<tr>
<td align="center"><bold>Wu S, 2015 (9)</bold></td>
<td align="center">Prospective cohort (Nurses' Health Study II, NHSII)</td>
<td align="center">USA</td>
<td align="center">89,220 women, 642 cases (1991–2009)</td>
<td align="center">Caffeinated coffee, FFQ</td>
<td align="left">Never/&lt; 1 cup per day/1-2 cups per day/&gt;2 cups per day</td>
<td align="center">Referent/0.80 (0.63–1.0)/0.79 (0.62–1.0)/0.70 (0.55–0.89)</td>
<td align="left">Age, family history, personal history of non-skin cancer, hair color, number of moles on legs or arms, sunburn reaction as a child/adolescent, number of blistering sunburns, time spent in direct sunlight since high school, cumulative ultraviolet flux since baseline, BMI, smoking, physical activity, total energy intake, alcohol intake, rotating night shifts, menopausal status, postmenopausal hormone use, consumption of decaffeinated coffee, caffeinated tea, decaffeinated tea, caffeinated carbonated beverages, decaffeinated carbonated beverages, and caffeine-containing chocolate.</td>
</tr>
<tr>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center">Decaffeinated coffee, FFQ</td>
<td align="left">Never/&lt; 1 cup per day/1-2 cups per day/&gt;2 cups per day</td>
<td align="center">Referent/0.96 (0.79–1.2)/1.10 (0.8–1.4)/0.93 (0.60–1.4)</td>
<td align="left">The same as above.</td>
</tr>
<tr>
<td align="left"><bold>First author, Year (Ref)</bold></td>
<td align="left"><bold>Study design</bold></td>
<td align="left"><bold>Region</bold></td>
<td align="left"><bold>Participants</bold></td>
<td align="left"><bold>Subgroup, exposure assessment</bold></td>
<td align="left"><bold>Intake category</bold></td>
<td align="center"><bold>OR/RR (95% CI)</bold></td>
<td align="left"><bold>Adjustments</bold></td>
</tr>
<tr>
<td align="left"/>
<td align="center">Prospective cohort (Nurses' Health Study, NHS)</td>
<td align="center">USA</td>
<td align="center">74,666 women, 841 cases (1980–2008)</td>
<td align="center">Caffeinated coffee, FFQ</td>
<td align="left">Never/&lt; 1 cup per day/1-2 cups per day/&gt;2 cups per day</td>
<td align="center">Referent/0.92 (0.72–1.2)/0.86 (0.68–1.1)/0.81 (0.65–1.0)</td>
<td align="left">The same as above.</td>
</tr>
<tr>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center">Decaffeinated coffee, FFQ</td>
<td align="left">Never/&lt; 1 cup per day/1-2 cups per day/&gt;2 cups per day</td>
<td align="center">Referent/1.20 (0.94–1.4)/1.10 (0.84–1.4)/0.98 (0.72–1.3)</td>
<td align="left">The same as above.</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Prospective cohort (Health Professionals Follow-up Study, HPFS)</td>
<td align="left">USA</td>
<td align="left">39,424 men, 771 cases (1986–2008)</td>
<td align="center">Caffeinated coffee, FFQ</td>
<td align="left">Never/&lt; 1 cupper day /1-2 cups per day/&gt;2 cups per day</td>
<td align="center">Referent/1.00 (0.83–1.3)/1.10 (0.84–1.3)/1.10 (0.86–1.3)</td>
<td align="left">The same as above.</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">Decaffeinated coffee, FFQ</td>
<td align="left">Never/&lt; 1 cupper day /1-2 cups per day/&gt;2 cups per day</td>
<td align="center">Referent/1.10 (0.92–1.3)/1.10 (0.91–1.4)/0.92 (0.68–1.2)</td>
<td align="left">The same as above.</td>
</tr>
<tr>
<td align="left"><bold>Loftfied E, 2015 (13)</bold></td>
<td align="center">Prospective (NIH-AARP Diet and Health Study, NIH-AARP)</td>
<td align="left">USA</td>
<td align="center">447,357 non-Hispanic whites, 2904 melanoma (1995–2006)</td>
<td align="left">Caffeinated coffee, FFQ</td>
<td align="left">None/≤1 cup per day/2-3 cups per day/≥ 4 cups per day</td>
<td align="center">Referent/0.89 (0.77–1.03)/0.91 (0.80–1.04)/0.75 (0.64–0.89)</td>
<td align="left">Age, sex, cigarette smoking and smoking intensity, cigar/pipe smoking, BMI, education, average daily alcohol intake, physical activity, family history of cancer, and July erythemal exposure.</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center"/>
<td align="center">Decaffeinated coffee, FFQ</td>
<td align="left">None/≤1 cup per day/2-3 cups per day/≥ 4 cups per day</td>
<td align="left">Referent/0.92 (0.79–1.06)/ 0.90 (0.77–1.05)/ 0.95 (0.76–1.18)</td>
<td align="left">The same as above.</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><bold>Abbreviations:</bold> 95% CI, 95% confidential interval; BMI, body mass index; FFQ, food frequency questionnaire; NA, not applicable; OR, odds ratio; RR, relative risk.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec014">
<title>Caffeinated coffee and MM risk</title>
<p>These seven articles included 10 individual subgroups have determined the association between the caffeinated coffee intake level and the risk for MM. The pooled RR was 0.81 (95% CI = 0.68–0.97) for those participants with the highest category of caffeinated coffee intake versus lowest category (<xref ref-type="fig" rid="pone.0147056.g002">Fig 2</xref>). Significant heterogeneity between the studies was noticed (Q = 24.64, df = 9, P = 0.003; I<sup>2</sup> = 63.5%). However, no individual study significantly affected the pooled estimate as suggested by the sensitivity analyses. The funnel plot suggested there was no potential publication bias for the included studies (<xref ref-type="supplementary-material" rid="pone.0147056.s001">S1 Fig</xref>), which was validated with the Egger’s test (P = 0.897).</p>
<fig id="pone.0147056.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0147056.g002</object-id>
<label>Fig 2</label>
<caption>
<title>The relative risks (RRs) of melanoma for the highest versus lowest quantity of caffeinated coffee intake in case-control studies and cohort studies.</title>
<p>The square represents the study-specific RR and the size of the squares reflects the statistical weight in the meta-analysis; horizontal lines represent the 95% confidential intervals (95% CIs); the diamond indicates the overall RR with its 95% CI under the random-effects model.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.g002" xlink:type="simple"/>
</fig>
<p>The meta-regression analyses suggested that none of the study-level characteristics (quality score, study design, gender of the participants, median or average follow-up time, study region, the lower boundary level of the highest and lowest categorized coffee intake level) significantly influence the results of multiple studies (<xref ref-type="supplementary-material" rid="pone.0147056.s006">S2 Table</xref>). In the stratification studies (<xref ref-type="table" rid="pone.0147056.t002">Table 2</xref>), we found the association between the caffeinated coffee intake level and the MM risk was more prominent in the cohort studies (pooled RR = 0.84, 95% CI = 0.71–0.99) than in the case-control studies (pooled RR = 0.76, 95% CI = 0.36–1.62). The protective effects for the caffeinated coffee against melanoma were statistically significant in women (pooled RR = 0.76, 95% CI = 0.61–0.95) but not in men (pooled RR = 1.11, 95% CI = 0.91–1.36).</p>
<table-wrap id="pone.0147056.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0147056.t002</object-id>
<label>Table 2</label> <caption><title>The stratification studies for the associations between caffeinated coffee or decaffeinated coffee intake level (highest vs. lowest percentile) and the risk for melanoma.</title></caption>
<alternatives>
<graphic id="pone.0147056.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Coffee Type</th>
<th align="center">Subgroup category</th>
<th align="center">Subgroup title</th>
<th align="center">No. of subgroups</th>
<th align="center">Pooled RR (95% CI)</th>
<th align="center">Q</th>
<th align="center">df</th>
<th align="center">P-value</th>
<th align="center">I<sup>2</sup></th>
<th align="center">Egger's test (P-value)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center"><bold>Caffeinated coffee</bold></td>
<td align="left">Overall</td>
<td align="left"/>
<td align="center">10</td>
<td align="center">0.81 (0.68–0.97)</td>
<td align="char" char=".">24.64</td>
<td align="center">9</td>
<td align="char" char=".">0.003</td>
<td align="center">63.5%</td>
<td align="char" char=".">0.897</td>
</tr>
<tr>
<td align="center"/>
<td align="left">Study Type</td>
<td align="left">Case-control</td>
<td align="center">2</td>
<td align="center">0.76 (0.36–1.62)</td>
<td align="char" char=".">6.06</td>
<td align="center">1</td>
<td align="char" char=".">0.014</td>
<td align="center">83.5%</td>
<td align="center">-</td>
</tr>
<tr>
<td align="center"/>
<td align="left"/>
<td align="left">Cohort</td>
<td align="center">8</td>
<td align="center">0.84 (0.71–0.99)</td>
<td align="char" char=".">16.39</td>
<td align="center">7</td>
<td align="char" char=".">0.022</td>
<td align="center">57.3%</td>
<td align="char" char=".">0.876</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Gender</td>
<td align="left">Women</td>
<td align="center">4</td>
<td align="center">0.76 (0.61–0.95)</td>
<td align="char" char=".">5.39</td>
<td align="center">3</td>
<td align="char" char=".">0.145</td>
<td align="center">44.3%</td>
<td align="char" char=".">0.630</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Both</td>
<td align="center">4</td>
<td align="center">0.76 (0.57–1.02)</td>
<td align="char" char=".">7.36</td>
<td align="center">3</td>
<td align="char" char=".">0.061</td>
<td align="center">59.2%</td>
<td align="char" char=".">0.699</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Men</td>
<td align="center">2</td>
<td align="center">1.11 (0.91–1.36)</td>
<td align="char" char=".">0.29</td>
<td align="center">1</td>
<td align="char" char=".">0.59</td>
<td align="center">0%</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Study region</td>
<td align="left">USA</td>
<td align="center">5</td>
<td align="center">0.85 (0.72–1.01)</td>
<td align="char" char=".">11.42</td>
<td align="center">4</td>
<td align="char" char=".">0.022</td>
<td align="center">65.0%</td>
<td align="char" char=".">0.639</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Other</td>
<td align="center">5</td>
<td align="center">0.77 (0.49–1.20)</td>
<td align="char" char=".">11.14</td>
<td align="center">4</td>
<td align="char" char=".">0.025</td>
<td align="center">64.1%</td>
<td align="char" char=".">0.409</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Study quality</td>
<td align="left">Higher</td>
<td align="center">7</td>
<td align="center">0.82 (0.68–0.99)</td>
<td align="char" char=".">15.49</td>
<td align="center">6</td>
<td align="char" char=".">0.017</td>
<td align="center">61.3%</td>
<td align="char" char=".">0.983</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Lower</td>
<td align="center">3</td>
<td align="center">0.83 (0.50–1.37)</td>
<td align="char" char=".">8.76</td>
<td align="center">2</td>
<td align="char" char=".">0.013</td>
<td align="center">77.2%</td>
<td align="char" char=".">0.268</td>
</tr>
<tr>
<td align="center"><bold>Decaffeinated coffee</bold></td>
<td align="left">Overall</td>
<td align="left"/>
<td align="center">6</td>
<td align="center">0.92 (0.81–1.05)</td>
<td align="char" char=".">0.94</td>
<td align="center">5</td>
<td align="char" char=".">0.967</td>
<td align="center">0%</td>
<td align="char" char=".">0.109</td>
</tr>
<tr>
<td align="center"/>
<td align="left">Study Type</td>
<td align="left">Case-control</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="center"/>
<td align="left"/>
<td align="left">Cohort</td>
<td align="center">5</td>
<td align="center">0.94 (0.82–1.08)</td>
<td align="char" char=".">0.60</td>
<td align="center">4</td>
<td align="char" char=".">0.964</td>
<td align="center">0%</td>
<td align="char" char=".">0.116</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Gender</td>
<td align="left">Women</td>
<td align="center">3</td>
<td align="center">0.94 (0.74–1.18)</td>
<td align="char" char=".">0.56</td>
<td align="center">2</td>
<td align="char" char=".">0.754</td>
<td align="center">0%</td>
<td align="char" char=".">0.125</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Men</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Study region</td>
<td align="left">USA</td>
<td align="center">5</td>
<td align="center">0.94 (0.82–1.08)</td>
<td align="char" char=".">0.60</td>
<td align="center">4</td>
<td align="char" char=".">0.964</td>
<td align="center">0%</td>
<td align="char" char=".">0.116</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Other</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Study quality</td>
<td align="left">Higher</td>
<td align="center">4</td>
<td align="center">0.95 (0.82–1.09)</td>
<td align="char" char=".">0.1</td>
<td align="center">3</td>
<td align="char" char=".">0.992</td>
<td align="center">0%</td>
<td align="char" char=".">0.804</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Lower</td>
<td align="center">2</td>
<td align="center">0.82 (0.60–1.11)</td>
<td align="char" char=".">0.12</td>
<td align="center">1</td>
<td align="char" char=".">0.727</td>
<td align="center">0%</td>
<td align="center">-</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>To evaluate the dose-response relationship between the caffeinated coffee intake and risk for MM, five articles with eight prospective cohort studies were included in the generalized least squares trend estimation analysis [<xref ref-type="bibr" rid="pone.0147056.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0147056.ref011">11</xref>–<xref ref-type="bibr" rid="pone.0147056.ref014">14</xref>]. We found a linear dose-response association between the caffeinated coffee intake level and MM risk (P for nonlinearity = 0.326; <xref ref-type="fig" rid="pone.0147056.g003">Fig 3</xref>). In the dose-response analysis, a 4.5% reduced MM risk (pooled RR = 0.955, 95% CI = 0.912–0.999) was noticed for per 1 cup/day increment of caffeinated coffee intake compared to non-drinkers (<xref ref-type="fig" rid="pone.0147056.g003">Fig 3</xref>).</p>
<fig id="pone.0147056.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0147056.g003</object-id>
<label>Fig 3</label>
<caption>
<title>The dose-relationship between the caffeinated coffee intake (cups/day) and the MM risk compared to non-drinkers (P for non-linearity = 0.326).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec015">
<title>Decaffeinated coffee and MM risk</title>
<p>Four studies (one case-control study and three cohort studies) with six subgroups have evaluated the association between decaffeinated coffee intake level and MM risk [<xref ref-type="bibr" rid="pone.0147056.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0147056.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0147056.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0147056.ref016">16</xref>] (<xref ref-type="table" rid="pone.0147056.t002">Table 2</xref>). The pooled RR was 0.92 (95% CI = 0.81–1.05) for those with highest versus lowest quantity of intake, suggested that decaffeinated coffee may not influence the MM risk (<xref ref-type="fig" rid="pone.0147056.g004">Fig 4</xref>). The Q-test (Q = 0.94, df = 5, P = 0.967) and the I<sup>2</sup> (0%) statistic suggested that no significant heterogeneity between the studies was evident. None of the study-level characteristics significantly affected the results of the multiple studies as suggested by the meta-regression analyses (<xref ref-type="supplementary-material" rid="pone.0147056.s007">S3 Table</xref>). The sensitivity analyses also found no individual study that significantly affected the pooled estimate. No publication bias was noticed as suggested by the funnel plot (<xref ref-type="supplementary-material" rid="pone.0147056.s002">S2 Fig</xref>) and the Egger’s test (P = 0.109). We also found no significant association between the decaffeinated coffee intake level and the MM risk in any stratification studies by study design, participants’ gender, quality score or study region (<xref ref-type="table" rid="pone.0147056.t002">Table 2</xref>).</p>
<fig id="pone.0147056.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0147056.g004</object-id>
<label>Fig 4</label>
<caption>
<title>The relative risks (RRs) of melanoma for the highest versus lowest quantity of decaffeinated coffee intake in case-control studies and cohort studies.</title>
<p>The square represents the study-specific RR and the size of the squares reflects the statistical weight in the meta-analysis; horizontal lines represent the 95% confidential intervals (95% CIs); the diamond indicates the overall RR with its 95% CI under the random-effects model.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.g004" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec016" sec-type="conclusions">
<title>Discussion</title>
<p>Regular coffee contains numerous bioactive compounds including polyphenols, diterpenes, trigonelline and caffeine <italic>etc</italic>. Epidemiological studies have reported that coffee may have preventative effects against cardiovascular disease and cancer caused mortality [<xref ref-type="bibr" rid="pone.0147056.ref024">24</xref>], type 2 diabetes [<xref ref-type="bibr" rid="pone.0147056.ref025">25</xref>], stroke [<xref ref-type="bibr" rid="pone.0147056.ref026">26</xref>], prostate cancer [<xref ref-type="bibr" rid="pone.0147056.ref027">27</xref>] and endometrial cancer [<xref ref-type="bibr" rid="pone.0147056.ref028">28</xref>]. In contrast, higher coffee intake was found to be associated with increased risk for lung cancer [<xref ref-type="bibr" rid="pone.0147056.ref029">29</xref>], bladder cancer [<xref ref-type="bibr" rid="pone.0147056.ref030">30</xref>] and gastric cancer [<xref ref-type="bibr" rid="pone.0147056.ref031">31</xref>]. Compounds in coffee have been reported to have anticancer activities against UV-light induced skin carcinogenesis in experimental tests [<xref ref-type="bibr" rid="pone.0147056.ref032">32</xref>–<xref ref-type="bibr" rid="pone.0147056.ref034">34</xref>]. It was supposed that higher intake of coffee, which is rich in caffeine, might lead to decreased risk of MM. Here, we firstly evaluated the association between the coffee intake level and the MM risk through meta-analysis methods and found that participants with more caffeinated coffee intake may have reduced MM risk. In contrast, no significant association was noticed between decaffeinated coffee intake level and MM risk. These data further provided evidence for the chemo-preventive effects of caffeine against the MM risk.</p>
<p>There were several mechanisms for the cancer preventative effects of caffeine against MM. Animal studies have suggested that caffeine inhibits the UVB-induced thymine dimers formation and reduces sunburn lesions in the epidermis of experimental mice [<xref ref-type="bibr" rid="pone.0147056.ref035">35</xref>,<xref ref-type="bibr" rid="pone.0147056.ref036">36</xref>]. Topical application of caffeine enhanced the UVB-induced apoptosis, but it was inactive on non-UVB-treated normal skin in the hairless SKH-1 mice [<xref ref-type="bibr" rid="pone.0147056.ref037">37</xref>]. Oral administration pre-treatment of caffeine also increased the p53-positive cells, p21-positive cells and apoptotic sunburn cells in the epidermis [<xref ref-type="bibr" rid="pone.0147056.ref037">37</xref>]. Meanwhile, oral administration of coffee had similar stimulatory effects on UV-induced cellular apoptosis in the epidermis of SKH-1 mice [<xref ref-type="bibr" rid="pone.0147056.ref034">34</xref>]. In tumor cells, caffeine could lead to selective radiosensitization of p53-deficiency cells through activating the p34<sup>cdc2</sup> kinase [<xref ref-type="bibr" rid="pone.0147056.ref038">38</xref>] and the radiosensitizing effects of the caffeine were also related to its inhibitory activities on the catalytic activity of both ATM and the related kinase, ATM and Rad3-related (ATR) [<xref ref-type="bibr" rid="pone.0147056.ref039">39</xref>]. Lu et al. found that administration of caffeine enhances the removal of DNA-damaged cells through inhibiting the ATR-mediated phosphorylation of Chk1 and prematurely increasing the number of cyclin B1-containing cells that undergo lethal mitosis [<xref ref-type="bibr" rid="pone.0147056.ref040">40</xref>]. Abnormal activity in the NF-kB signaling pathway is critical to the transformation of skin cells in the tumorigenesis, and caffeine is reported to have inhibitory activities on UV-mediated NF-kB activation in melanoma cells [<xref ref-type="bibr" rid="pone.0147056.ref041">41</xref>]. Caffeine also inhibited the lung metastasis and reduced the tumor growth of the melanoma cells [<xref ref-type="bibr" rid="pone.0147056.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0147056.ref042">42</xref>]. Therefore, there it is biologically plausible that higher caffeine intake via coffee or tea may reduce the MM risk in certain populations.</p>
<p>Although we did not find a statistically inverse relationship between decaffeinated coffee intake level and the MM risk, we could not exclude the possibility that there were other potential anticancer ingredients in coffee besides the caffeine. The predominant chlorogenic acid in coffee, 5-O-caffeoylquinic acid and its metabolite caffeic acid have been reported to suppress the UVB-induced skin carcinogenesis by inhibiting the cyclooxygenase-2 (COX-2) expression [<xref ref-type="bibr" rid="pone.0147056.ref043">43</xref>] or directly inhibiting the ERK1/2 activities [<xref ref-type="bibr" rid="pone.0147056.ref032">32</xref>]. The cellular studies have revealed that the diterpenes cafestol and kahweol could induce the cellular apoptosis [<xref ref-type="bibr" rid="pone.0147056.ref044">44</xref>] and protest against the oxidative stress and DNA damage [<xref ref-type="bibr" rid="pone.0147056.ref045">45</xref>]. <italic>In vivo</italic> studies have found that topical administration of diterpenes inhibits the inflammation in epidermal cells of mice [<xref ref-type="bibr" rid="pone.0147056.ref005">5</xref>]. The nicotinic acid and nicotinamide generated from trigonelline in coffee roasting have protective roles against UVB-induced skin carcinogenesis in cellular models [<xref ref-type="bibr" rid="pone.0147056.ref046">46</xref>–<xref ref-type="bibr" rid="pone.0147056.ref048">48</xref>]. Considering the important role of caffeine in the suppression of tumorigenesis, the anticancer activities of decaffeinated coffee could be relatively lower and studies with larger sample size are warranted to reveal the anticancer activities of decaffeinated coffee.</p>
<p>Meta-regression studies suggested that no study-level characteristics including study design, study quality score, median or average following-up time, participant gender, or level of coffee intake significantly influence the heterogeneity between the studies. These factors may account for a small proportion of the heterogeneity between the studies. Other factors including the UV exposure level, the amount of the caffeine in the coffee, caffeine intake from other sources, the preparation method of coffee etc. may also contribute to the heterogeneity between the studies. In the stratification studies, we found the evidence for the protective effects of caffeinated coffee was more prominent in cohort studies than in case-control studies, which may be due to the relative higher quality of the cohort studies (<xref ref-type="supplementary-material" rid="pone.0147056.s005">S1 Table</xref>) and smaller sample size from case-control studies. Interestingly, we found significant protective effects against melanoma in women, but not men, regarding the use of caffeinated coffee. It has been suggested that men usually received less UV exposure than the women due to their different dressing styles, and the incidence of melanoma is higher for women. Moreover, men who have higher caffeinated coffee intake levels usually ingest higher levels of alcohol and/or with heavier smoking habits, both of which are associated with increased risk for melanoma. Thus, the protective roles of caffeinated coffee were not as apparent as in women for men.</p>
<p>There are several limitations for the current study. First, the ranges for coffee intake differed between the studies, which may lead to the heterogeneity of risk estimates between the groups. The dose-response analysis also found a significantly negative relationship between caffeinated coffee intake level and MM risk in which the RR was 0.96 (95% CI = 0.94–0.98) per 1 cup/day caffeinated coffee intake compared to non-drinkers. The coffee the participants consumed are typologically different both in preparation and in the coffee amount present in the cup, which may contribute to the heterogeneity between the studies. Second, all the studies were performed in the United States or European countries, so whether the associations noticed here could be externalized to other populations are still unknown. Larger prospective studies performed in other countries or populations are warranted. Third, the interactions between caffeinated coffee intake level and UV-light exposure level and their roles in the MM risk are largely unknown as caffeine reduced the UV irradiation induced DNA damage and enhanced UV induced cellular apoptosis. Fourth, in the meta-analysis of published studies, publication bias may lead to a biased false positive association as the small studies with null results may not yet published. Although we found no statistically significant publication bias here, we could not exclude the possibility that such bias existed. Last but not the least, the estimates from the individual studies was adjusted for different cofounding factors, which may also contribute to the heterogeneity between the studies and the interactions between the coffee intake level the cofounding factors in the melanoma risk were also hard to determine.</p>
<p>In conclusion, this meta-analysis found that caffeinated coffee intake was negatively associated with the MM risk, but not so for the intake of decaffeinated coffee. Considering the high prevalence of coffee consumption and the rising incidence rate of melanoma, our study may provide important public health implications in the prevention of MM. However, more studies, especially the intervention studies are warranted to fully elucidate the chemo-preventive effects of caffeinated coffee against MM.</p>
</sec>
<sec id="sec017">
<title>Supporting Information</title>
<supplementary-material id="pone.0147056.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Funnel plot of the association between higher caffeinated coffee intake and the melanoma risk compared to those of lower intake level for publication bias identification.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0147056.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Funnel plot of the association between higher decaffeinated coffee intake and the melanoma risk compared to those of lower intake level for publication bias identification.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0147056.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.s003" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>MOOSE Checklist for the meta-analysis study.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0147056.s004" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.s004" xlink:type="simple">
<label>S2 File</label>
<caption>
<title>PRISMA Checklist for the meta-analysis.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0147056.s005" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.s005" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>The study quality for each subgroup studies according to the Newcastle-Ottawa quality scale.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0147056.s006" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.s006" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Univariate meta-regression analysis between the logrithm relative risk of melanoma for the highest vs. lowest quantile of caffeinated coffee intake and the basic characteristics of the study.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0147056.s007" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0147056.s007" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>Univariate meta-regression analysis between the logrithm relative risk of melanoma for the highest vs. lowest quantile of decaffeinated coffee intake and the basic characteristics of the study.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>95% CI</term>
<def><p>95% confidential interval</p></def>
</def-item>
<def-item><term>MM</term>
<def><p>malignant melanoma</p></def>
</def-item>
<def-item><term>OR</term>
<def><p>odds ratio</p></def>
</def-item>
<def-item><term>RR</term>
<def><p>relative risk</p></def>
</def-item>
<def-item><term>UV</term>
<def><p>ultra-violet</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pone.0147056.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Rambhatla</surname> <given-names>PV</given-names></name>, <name name-style="western"><surname>Eide</surname> <given-names>MJ</given-names></name> (<year>2015</year>) <article-title>Socioeconomic and lifestyle factors and melanoma: a systematic review</article-title>. <source>Br J Dermatol</source> <volume>172</volume>: <fpage>885</fpage>–<lpage>915</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/bjd.13500" xlink:type="simple">10.1111/bjd.13500</ext-link></comment> <object-id pub-id-type="pmid">25354495</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bakos</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Mastroeni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bonamigo</surname> <given-names>RR</given-names></name>, <name name-style="western"><surname>Melchi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Pasquini</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Fortes</surname> <given-names>C</given-names></name> (<year>2013</year>) <article-title>A melanoma risk score in a Brazilian population</article-title>. <source>An Bras Dermatol</source> <volume>88</volume>: <fpage>226</fpage>–<lpage>232</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/S0365-05962013000200007" xlink:type="simple">10.1590/S0365-05962013000200007</ext-link></comment> <object-id pub-id-type="pmid">23739694</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Waure</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Quaranta</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gualano</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Cadeddu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Jovic-Vranes</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Djikanovic</surname> <given-names>B</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>Systematic review of studies investigating the association between dietary habits and cutaneous malignant melanoma</article-title>. <source>Public Health</source> <volume>129</volume>: <fpage>1099</fpage>–<lpage>1113</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.puhe.2015.06.015" xlink:type="simple">10.1016/j.puhe.2015.06.015</ext-link></comment> <object-id pub-id-type="pmid">26212104</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conney</surname> <given-names>AH</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>YP</given-names></name>, <name name-style="western"><surname>Lou</surname> <given-names>YR</given-names></name>, <name name-style="western"><surname>Kawasumi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nghiem</surname> <given-names>P</given-names></name> (<year>2013</year>) <article-title>Mechanisms of Caffeine-Induced Inhibition of UVB Carcinogenesis</article-title>. <source>Front Oncol</source> <volume>3</volume>: <fpage>144</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fonc.2013.00144" xlink:type="simple">10.3389/fonc.2013.00144</ext-link></comment> <object-id pub-id-type="pmid">23785666</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Wen</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Palanisamy</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Topical application of marine briarane-type diterpenes effectively inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and dermatitis in murine skin</article-title>. <source>J Biomed Sci</source> <volume>18</volume>: <fpage>94</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1423-0127-18-94" xlink:type="simple">10.1186/1423-0127-18-94</ext-link></comment> <object-id pub-id-type="pmid">22189182</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>WJ</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>BT</given-names></name> (<year>2006</year>) <article-title>Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols</article-title>. <source>Carcinogenesis</source> <volume>27</volume>: <fpage>269</fpage>–<lpage>277</lpage>. <object-id pub-id-type="pmid">16081510</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gude</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Menon</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Rao</surname> <given-names>SG</given-names></name> (<year>2001</year>) <article-title>Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells</article-title>. <source>J Exp Clin Cancer Res</source> <volume>20</volume>: <fpage>287</fpage>–<lpage>292</lpage>. <object-id pub-id-type="pmid">11484989</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higuchi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mitsuhashi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Saitoh</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Maebayashi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sakurai</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Akimoto</surname> <given-names>T</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Caffeine enhanced radiosensitivity of rat tumor cells with a mutant-type p53 by inducing apoptosis in a p53-independent manner</article-title>. <source>Cancer Lett</source> <volume>152</volume>: <fpage>157</fpage>–<lpage>162</lpage>. <object-id pub-id-type="pmid">10773407</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Cho</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Hunter</surname> <given-names>DJ</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>Caffeine Intake, Coffee Consumption, and Risk of Cutaneous Malignant Melanoma</article-title>. <source>Epidemiology</source> <volume>26</volume>: <fpage>898</fpage>–<lpage>908</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/EDE.0000000000000360" xlink:type="simple">10.1097/EDE.0000000000000360</ext-link></comment> <object-id pub-id-type="pmid">26172864</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fortes</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mastroeni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Boffetta</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Antonelli</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Pilla</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Bottà</surname> <given-names>G</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>The protective effect of coffee consumption on cutaneous melanoma risk and the role of GSTM1 and GSTT1 polymorphisms</article-title>. <source>Cancer Causes Control</source> <volume>24</volume>: <fpage>1779</fpage>–<lpage>1787</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10552-013-0255-4" xlink:type="simple">10.1007/s10552-013-0255-4</ext-link></comment> <object-id pub-id-type="pmid">23860951</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Veierod</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Thelle</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Laake</surname> <given-names>P</given-names></name> (<year>1997</year>) <article-title>Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women</article-title>. <source>Int J Cancer</source> <volume>71</volume>: <fpage>600</fpage>–<lpage>604</lpage>. <object-id pub-id-type="pmid">9178814</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Reeves</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>Qian</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sturgeon</surname> <given-names>SR</given-names></name> (<year>2015</year>) <article-title>Coffee, tea, and melanoma risk among postmenopausal women</article-title>. <source>Eur J Cancer Prev</source> <volume>24</volume>: <fpage>347</fpage>–<lpage>352</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/CEJ.0000000000000093" xlink:type="simple">10.1097/CEJ.0000000000000093</ext-link></comment> <object-id pub-id-type="pmid">25325307</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Loftfield</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Freedman</surname> <given-names>ND</given-names></name>, <name name-style="western"><surname>Graubard</surname> <given-names>BI</given-names></name>, <name name-style="western"><surname>Hollenbeck</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Shebl</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Mayne</surname> <given-names>ST</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>Coffee drinking and cutaneous melanoma risk in the NIH-AARP diet and health study</article-title>. <source>J Natl Cancer Inst</source> <volume>107</volume>.</mixed-citation></ref>
<ref id="pone.0147056.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nilsson</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Johansson</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Lenner</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lindahl</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Van Guelpen</surname> <given-names>B</given-names></name> (<year>2010</year>) <article-title>Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study</article-title>. <source>Cancer Causes Control</source> <volume>21</volume>: <fpage>1533</fpage>–<lpage>1544</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10552-010-9582-x" xlink:type="simple">10.1007/s10552-010-9582-x</ext-link></comment> <object-id pub-id-type="pmid">20512657</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stensvold</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Jacobsen</surname> <given-names>BK</given-names></name> (<year>1994</year>) <article-title>Coffee and cancer: a prospective study of 43,000 Norwegian men and women</article-title>. <source>Cancer Causes Control</source> <volume>5</volume>: <fpage>401</fpage>–<lpage>408</lpage>. <object-id pub-id-type="pmid">7999961</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naldi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Gallus</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tavani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Imberti</surname> <given-names>GL</given-names></name>, <name name-style="western"><surname>La Vecchia</surname> <given-names>C</given-names></name>, <collab>Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology</collab> (<year>2004</year>) <article-title>Risk of melanoma and vitamin A, coffee and alcohol: a case-control study from Italy</article-title>. <source>Eur J Cancer Prev</source> <volume>13</volume>: <fpage>503</fpage>–<lpage>508</lpage>. <object-id pub-id-type="pmid">15548944</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Song</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Qureshi</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>J</given-names></name> (<year>2012</year>) <article-title>Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin</article-title>. <source>Cancer Res</source> <volume>72</volume>: <fpage>3282</fpage>–<lpage>3289</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/0008-5472.CAN-11-3511" xlink:type="simple">10.1158/0008-5472.CAN-11-3511</ext-link></comment> <object-id pub-id-type="pmid">22752299</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferrucci</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Cartmel</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Molinaro</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Leffell</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Bale</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Mayne</surname> <given-names>ST</given-names></name> (<year>2014</year>) <article-title>Tea, coffee, and caffeine and early-onset basal cell carcinoma in a case-control study</article-title>. <source>Eur J Cancer Prev</source> <volume>23</volume>: <fpage>296</fpage>–<lpage>302</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/CEJ.0000000000000037" xlink:type="simple">10.1097/CEJ.0000000000000037</ext-link></comment> <object-id pub-id-type="pmid">24841641</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stang</surname> <given-names>A</given-names></name> (<year>2010</year>) <article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title>. <source>Eur J Epidemiol</source> <volume>25</volume>: <fpage>603</fpage>–<lpage>605</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10654-010-9491-z" xlink:type="simple">10.1007/s10654-010-9491-z</ext-link></comment> <object-id pub-id-type="pmid">20652370</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Orsini</surname> <given-names>N</given-names></name> <name name-style="western"><surname>B</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Greenland</surname> <given-names>S</given-names></name> (<year>2006</year>) <article-title>Generalized least squares for trend estimation of summarized dose-response data</article-title>. <source>Stata Journal</source>: <fpage>40</fpage>–<lpage>57</lpage>.</mixed-citation></ref>
<ref id="pone.0147056.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crippa</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Discacciati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Larsson</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Wolk</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Orsini</surname> <given-names>N</given-names></name> (<year>2014</year>) <article-title>Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis</article-title>. <source>Am J Epidemiol</source> <volume>180</volume>: <fpage>763</fpage>–<lpage>775</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/aje/kwu194" xlink:type="simple">10.1093/aje/kwu194</ext-link></comment> <object-id pub-id-type="pmid">25156996</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>W</given-names></name> (<year>2014</year>) <article-title>Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies</article-title>. <source>Eur J Nutr</source> <volume>53</volume>: <fpage>25</fpage>–<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00394-013-0603-x" xlink:type="simple">10.1007/s00394-013-0603-x</ext-link></comment> <object-id pub-id-type="pmid">24150256</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larsson</surname> <given-names>SC</given-names></name> (<year>2014</year>) <article-title>Coffee, tea, and cocoa and risk of stroke</article-title>. <source>Stroke</source> <volume>45</volume>: <fpage>309</fpage>–<lpage>314</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/STROKEAHA.113.003131" xlink:type="simple">10.1161/STROKEAHA.113.003131</ext-link></comment> <object-id pub-id-type="pmid">24326448</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>GH</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>XC</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>TB</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>P</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>Coffee consumption and prostate cancer risk: a meta-analysis of cohort studies</article-title>. <source>Nutr Cancer</source> <volume>67</volume>: <fpage>392</fpage>–<lpage>400</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/01635581.2015.1004727" xlink:type="simple">10.1080/01635581.2015.1004727</ext-link></comment> <object-id pub-id-type="pmid">25706900</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Luo</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>JG</given-names></name> (<year>2015</year>) <article-title>Coffee consumption and risk of endometrial cancer: a dose-response meta-analysis of prospective cohort studies</article-title>. <source>Sci Rep</source> <volume>5</volume>: <fpage>13410</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep13410" xlink:type="simple">10.1038/srep13410</ext-link></comment> <object-id pub-id-type="pmid">26302813</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xie</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Qin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nan</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Su</surname> <given-names>Y</given-names></name> (<year>2015</year>) <article-title>Coffee consumption and the risk of lung cancer: an updated meta-analysis of epidemiological studies</article-title>. <source>Eur J Clin Nutr</source>. [Epub ahead of print]</mixed-citation></ref>
<ref id="pone.0147056.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Tong</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>Q</given-names></name> (<year>2015</year>) <article-title>Coffee consumption and bladder cancer: a meta-analysis of observational studies</article-title>. <source>Sci Rep</source> <volume>5</volume>: <fpage>9051</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep09051" xlink:type="simple">10.1038/srep09051</ext-link></comment> <object-id pub-id-type="pmid">25761588</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shen</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Cao</surname> <given-names>H</given-names></name> (<year>2015</year>) <article-title>Coffee consumption and risk of gastric cancer: an updated meta-analysis</article-title>. <source>Clin Res Hepatol Gastroenterol</source> <volume>39</volume>: <fpage>245</fpage>–<lpage>253</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.clinre.2014.09.005" xlink:type="simple">10.1016/j.clinre.2014.09.005</ext-link></comment> <object-id pub-id-type="pmid">25459992</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Malakhova</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kurinov</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Yao</surname> <given-names>K</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Caffeic acid directly targets ERK1/2 to attenuate solar UV-induced skin carcinogenesis</article-title>. <source>Cancer Prev Res (Phila)</source> <volume>7</volume>: <fpage>1056</fpage>–<lpage>1066</lpage>.</mixed-citation></ref>
<ref id="pone.0147056.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>YP</given-names></name>, <name name-style="western"><surname>Lou</surname> <given-names>YR</given-names></name>, <name name-style="western"><surname>Peng</surname> <given-names>QY</given-names></name>, <name name-style="western"><surname>Nghiem</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Conney</surname> <given-names>AH</given-names></name> (<year>2011</year>) <article-title>Caffeine decreases phospho-Chk1 (Ser317) and increases mitotic cells with cyclin B1 and caspase 3 in tumors from UVB-treated mice</article-title>. <source>Cancer Prev Res (Phila)</source> <volume>4</volume>: <fpage>1118</fpage>–<lpage>1125</lpage>.</mixed-citation></ref>
<ref id="pone.0147056.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conney</surname> <given-names>AH</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Lou</surname> <given-names>YR</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Stimulatory effect of oral administration of tea, coffee or caffeine on UVB-induced apoptosis in the epidermis of SKH-1 mice</article-title>. <source>Toxicol Appl Pharmacol</source> <volume>224</volume>: <fpage>209</fpage>–<lpage>213</lpage>. <object-id pub-id-type="pmid">17188726</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zajdela</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Latarjet</surname> <given-names>R</given-names></name> (<year>1978</year>) <article-title>Inhibition of skin carcinogenesis in vivo by caffeine and other agents</article-title>. <source>Natl Cancer Inst Monogr</source>: <fpage>133</fpage>–<lpage>140</lpage>.</mixed-citation></ref>
<ref id="pone.0147056.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bowden</surname> <given-names>GT</given-names></name>, <name name-style="western"><surname>Fusenig</surname> <given-names>NE</given-names></name> (<year>1980</year>) <article-title>Caffeine inhibition of postreplication repair of UV-damaged DNA in mouse epidermal cells</article-title>. <source>Chem Biol Interact</source> <volume>33</volume>: <fpage>101</fpage>–<lpage>113</lpage>. <object-id pub-id-type="pmid">7438289</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>YP</given-names></name>, <name name-style="western"><surname>Lou</surname> <given-names>YR</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>XH</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Brash</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>MT</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice</article-title>. <source>Cancer Res</source> <volume>60</volume>: <fpage>4785</fpage>–<lpage>4791</lpage>. <object-id pub-id-type="pmid">10987287</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yao</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Akhtar</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>McKenna</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Bedi</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>Sidransky</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Mabry</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase</article-title>. <source>Nat Med</source> <volume>2</volume>: <fpage>1140</fpage>–<lpage>1143</lpage>. <object-id pub-id-type="pmid">8837615</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sarkaria</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Busby</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Tibbetts</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Roos</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Taya</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Karnitz</surname> <given-names>LM</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine</article-title>. <source>Cancer Res</source> <volume>59</volume>: <fpage>4375</fpage>–<lpage>4382</lpage>. <object-id pub-id-type="pmid">10485486</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>YP</given-names></name>, <name name-style="western"><surname>Lou</surname> <given-names>YR</given-names></name>, <name name-style="western"><surname>Peng</surname> <given-names>QY</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Nghiem</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Conney</surname> <given-names>AH</given-names></name>. (<year>2008</year>) <article-title>Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice</article-title>. <source>Cancer Res</source> <volume>68</volume>: <fpage>2523</fpage>–<lpage>2529</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/0008-5472.CAN-07-5955" xlink:type="simple">10.1158/0008-5472.CAN-07-5955</ext-link></comment> <object-id pub-id-type="pmid">18381462</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ravi</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Muniyappa</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Das</surname> <given-names>KC</given-names></name> (<year>2008</year>) <article-title>Caffeine inhibits UV-mediated NF-kappaB activation in A2058 melanoma cells: an ATM-PKCdelta-p38 MAPK-dependent mechanism</article-title>. <source>Mol Cell Biochem</source> <volume>308</volume>: <fpage>193</fpage>–<lpage>200</lpage>. <object-id pub-id-type="pmid">17932622</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lentini</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kleinman</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Mattioli</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Autuori-Pezzoli</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Nicolini</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Pietrini</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation</article-title>. <source>Melanoma Res</source> <volume>8</volume>: <fpage>131</fpage>–<lpage>137</lpage>. <object-id pub-id-type="pmid">9610865</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kang</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>Shin</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Jung</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Bode</surname> <given-names>AM</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression</article-title>. <source>Carcinogenesis</source> <volume>30</volume>: <fpage>321</fpage>–<lpage>330</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/carcin/bgn282" xlink:type="simple">10.1093/carcin/bgn282</ext-link></comment> <object-id pub-id-type="pmid">19073879</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Chae</surname> <given-names>JI</given-names></name>, <name name-style="western"><surname>Shim</surname> <given-names>JH</given-names></name> (<year>2012</year>) <article-title>Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma</article-title>. <source>J Biomed Sci</source> <volume>19</volume>: <fpage>60</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1423-0127-19-60" xlink:type="simple">10.1186/1423-0127-19-60</ext-link></comment> <object-id pub-id-type="pmid">22734486</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Jeong</surname> <given-names>HG</given-names></name> (<year>2007</year>) <article-title>Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage</article-title>. <source>Toxicol Lett</source> <volume>173</volume>: <fpage>80</fpage>–<lpage>87</lpage>. <object-id pub-id-type="pmid">17689207</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lang</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Yagar</surname> <given-names>EF</given-names></name>, <name name-style="western"><surname>Eggers</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hofmann</surname> <given-names>T</given-names></name> (<year>2008</year>) <article-title>Quantitative investigation of trigonelline, nicotinic acid, and nicotinamide in foods, urine, and plasma by means of LC-MS/MS and stable isotope dilution analysis</article-title>. <source>J Agric Food Chem</source> <volume>56</volume>: <fpage>11114</fpage>–<lpage>11121</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1021/jf802838s" xlink:type="simple">10.1021/jf802838s</ext-link></comment> <object-id pub-id-type="pmid">19007232</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thompson</surname> <given-names>BC</given-names></name>, <name name-style="western"><surname>Halliday</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Damian</surname> <given-names>DL</given-names></name> (<year>2015</year>) <article-title>Nicotinamide enhances repair of arsenic and ultraviolet radiation-induced DNA damage in HaCaT keratinocytes and ex vivo human skin</article-title>. <source>PLoS One</source> <volume>10</volume>: <fpage>e0117491</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0117491" xlink:type="simple">10.1371/journal.pone.0117491</ext-link></comment> <object-id pub-id-type="pmid">25658450</object-id></mixed-citation></ref>
<ref id="pone.0147056.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thompson</surname> <given-names>BC</given-names></name>, <name name-style="western"><surname>Surjana</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Halliday</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Damian</surname> <given-names>DL</given-names></name> (<year>2014</year>) <article-title>Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes</article-title>. <source>Exp Dermatol</source> <volume>23</volume>: <fpage>509</fpage>–<lpage>511</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/exd.12430" xlink:type="simple">10.1111/exd.12430</ext-link></comment> <object-id pub-id-type="pmid">24798949</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>